SCHEMBL30262121

SCHEMBL30262121

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.59
▸ F2 P00734 4/20 0.59
▸ NTSR1 P30989 2/20 0.56
▸ NTSR2 O95665 1/20 0.56
▸ HCRTR1 O43613 1/20 0.55
▸ HCRTR2 O43614 1/20 0.55
▸ NPY2R P49146 2/20 0.55
▸ NPY4R P50391 2/20 0.55
▸ NPY5R Q15761 2/20 0.55
▸ NPY1R P25929 1/20 0.55
▸ EP300 Q09472 1/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ TFPI P10646 1/20 0.54
▸ KDM1A O60341 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30432355 0.93 CALCR (0.65) CALCRF2HCRTR1HCRTR2NPY2R
SCHEMBL19003817 0.89 NTSR1 (0.63) F2NTSR1NTSR2NPY2RNPY4R
SCHEMBL30262137 0.89 NTSR1 (0.58) CALCRF2NTSR1NTSR2
SCHEMBL29509548 0.89 TFPI (0.65) CALCRF2NPY2RNPY4RNPY5R
SCHEMBL31199057 0.88 NPY2R (0.60) CALCRF2NTSR1NTSR2HCRTR1
SCHEMBL30831411 0.88 CALCR (0.63) CALCRF2HCRTR1HCRTR2NPY2R
SCHEMBL29377200 0.87 NTSR1 (0.61) F2NTSR1NTSR2NPY2RNPY4R
SCHEMBL29420255 0.87 NTSR1 (0.61) CALCRF2NTSR1NTSR2NPY2R
SCHEMBL30712883 0.87 CALCR (0.62) CALCRF2TFPIKDM1A
SCHEMBL29420253 0.87 NTSR1 (0.61) NTSR1NTSR2NPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback